DE60024239D1 - Ein verbessertes reversibles verhütungsmittel für männer und frauen - Google Patents

Ein verbessertes reversibles verhütungsmittel für männer und frauen

Info

Publication number
DE60024239D1
DE60024239D1 DE60024239T DE60024239T DE60024239D1 DE 60024239 D1 DE60024239 D1 DE 60024239D1 DE 60024239 T DE60024239 T DE 60024239T DE 60024239 T DE60024239 T DE 60024239T DE 60024239 D1 DE60024239 D1 DE 60024239D1
Authority
DE
Germany
Prior art keywords
contraceptive
electrically conducting
particles
polymer
men
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60024239T
Other languages
English (en)
Other versions
DE60024239T2 (de
Inventor
Sujoy Kumar Guha
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE60024239D1 publication Critical patent/DE60024239D1/de
Application granted granted Critical
Publication of DE60024239T2 publication Critical patent/DE60024239T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60024239T 1999-03-17 2000-03-16 Ein verbessertes reversibles verhütungsmittel für männer und frauen Expired - Lifetime DE60024239T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN415DE1999 1999-03-17
INDE041599 1999-03-17
PCT/IN2000/000023 WO2000054746A1 (en) 1999-03-17 2000-03-16 An improved reversible contraceptive for male and female

Publications (2)

Publication Number Publication Date
DE60024239D1 true DE60024239D1 (de) 2005-12-29
DE60024239T2 DE60024239T2 (de) 2006-08-17

Family

ID=11089702

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60024239T Expired - Lifetime DE60024239T2 (de) 1999-03-17 2000-03-16 Ein verbessertes reversibles verhütungsmittel für männer und frauen

Country Status (6)

Country Link
EP (1) EP1162948B1 (de)
AT (1) ATE310503T1 (de)
AU (1) AU3322600A (de)
CA (1) CA2367414C (de)
DE (1) DE60024239T2 (de)
WO (1) WO2000054746A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2264172T (pt) 2002-04-05 2017-12-06 Roche Innovation Ct Copenhagen As Compostos oligoméricos para a modulação da expressão do hif-1α.
US8048086B2 (en) 2004-02-25 2011-11-01 Femasys Inc. Methods and devices for conduit occlusion
US9238127B2 (en) 2004-02-25 2016-01-19 Femasys Inc. Methods and devices for delivering to conduit
US8048101B2 (en) 2004-02-25 2011-11-01 Femasys Inc. Methods and devices for conduit occlusion
US8052669B2 (en) 2004-02-25 2011-11-08 Femasys Inc. Methods and devices for delivery of compositions to conduits
US9447138B2 (en) 2004-11-09 2016-09-20 Roche Innovation Center Copenhagen A/S Potent LNA oligonucleotides for the inhibition of HIF-1a expression
US9554826B2 (en) 2008-10-03 2017-01-31 Femasys, Inc. Contrast agent injection system for sonographic imaging
US10070888B2 (en) 2008-10-03 2018-09-11 Femasys, Inc. Methods and devices for sonographic imaging
WO2013061341A1 (en) 2011-10-28 2013-05-02 Sujoy Kumar Guha An improved intra-uterine contraceptive device
US9861515B2 (en) 2013-10-17 2018-01-09 Revolution Contraceptives Llc Compositions and methods relating to an occlusive polymer hydrogel
WO2015114481A1 (en) * 2014-01-31 2015-08-06 Sujoy Kumar Guha Contraceptive formulation and method of its preparation and use
US20200188164A1 (en) * 2018-12-12 2020-06-18 Lucas J. Myslinski Device, method and system for implementing a physical area network for reproductive protection

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4040417A (en) * 1970-12-01 1977-08-09 G. D. Searle & Co. Intrauterine device
US4185618A (en) * 1976-01-05 1980-01-29 Population Research, Inc. Promotion of fibrous tissue growth in fallopian tubes for female sterilization
SE7608618L (sv) * 1976-07-30 1978-02-01 Medline Ab Igensettning av kanaler
CN85108504A (zh) * 1985-11-14 1987-05-20 西北大学 一种制备节育显影粘堵剂的工艺方法
US5488075A (en) * 1994-09-20 1996-01-30 Guha; Sujoy K. Contraceptive for use by a male

Also Published As

Publication number Publication date
WO2000054746A1 (en) 2000-09-21
ATE310503T1 (de) 2005-12-15
EP1162948B1 (de) 2005-11-23
CA2367414C (en) 2007-06-26
DE60024239T2 (de) 2006-08-17
EP1162948A1 (de) 2001-12-19
AU3322600A (en) 2000-10-04
CA2367414A1 (en) 2000-09-21

Similar Documents

Publication Publication Date Title
DE60024239D1 (de) Ein verbessertes reversibles verhütungsmittel für männer und frauen
KR910018069A (ko) 입상물 및 그의 제조방법
Otocka et al. Ionic bonding in butadiene copolymers. I. Network formation
Li et al. Synthesis and characterization of soluble polyaniline
GB1533662A (en) Refractory granular embedding composition for electric heating coils
Kraft et al. Synthesis and crystal structure of diiodine (V/VII) hexaoxide: An intermediate between a molecular and a polymer solid
Rataiczak et al. Electron spin resonance characterization of the anion radicals of singly, doubly, and triply reduced C60 in liquid solutions
JPH0369153B2 (de)
Oberoi et al. Evaluation of an index based on van't Hoff equation to predict PEG-drug eutectic composition
Starov et al. Investigation of MgO Effect on the Melting Temperature of BOF Slags
JPS5527471A (en) Oxide film forming method for granular silicon for flux
KR950704799A (ko) 산화물 자성재료 및 그 제조 방법(magnetic oxide and process for producing same)
Lovell et al. Synthesis and characterisation of poly (arylene sulfides), 7. Transitional behavior of random and block copoly (arylene sulfides)
Nikolaev et al. The development of production technology for superalloy powder materials
SU954462A1 (ru) Способ изготовлени безобжиговых опускованных материалов
SU1351894A1 (ru) Стекло дл термочувствительных датчиков
Berglund FeCrAl Alloy Shows Good Hot Strength
Pinchuk et al. The Effect of Small Scandium Additions on the Magnetic Susceptibility of Iron at High Temperatures
JPH02294324A (ja) 導電性高分子分散液の作製方法
Zhuravlev et al. The study and testing of ecologically pure technology for manufacture of the raw monomaterial for the blast furnace process in the form of the self-fluxing local sinters from the pellets
JPH04183813A (ja) Ｆｅ―Ｍｎ合金の添加方法
JPS60239307A (ja) セレン合金の製造方法
Joshi et al. Processing of electrical contacts grade Ag-ZnO powders by alternative routes
JPH01282266A (ja) 組成物
Vlasie et al. Anthracite Calcination and Finished Product Characterization

Legal Events

Date Code Title Description
8364 No opposition during term of opposition